Search
Font size
click to adjust
Page tools
- Add to info basket
- Black-and-white version
- Text version
- Printer friendly version
- Bookmark this page
Recommended Links
Podcast Center
News
03/11/10, General Medicine FDA Grants Orphan Drug Status to Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Berlin, March 11, 2010 – Bayer Schering Pharma AG, Germany, announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration (FDA) for the ciprofloxacin... more
03/10/10, Research & Development MR contrast agents for diagnosis of breast cancer Bayer starts Phase III study to evaluate efficacy and safety of Gadovist® in magnetic resonance mammography more
02/26/10, Company Bayer successful in a difficult environment Group sales EUR 31,168 million (minus 5.3 percent) / EBITDA before special items EUR 6,472 million (minus 6.6 percent) / Net income EUR 1,359 million (minus 20.9 percent) / Net cash flow significantl... more
In Focus
02/22/2010
IMI – Innovative Medicines Initiative
EMTRAIN: European platform for new educational and training programs in pharmaceutical medicine...
more